| Purpose: The purpose of this research is to observe the clinical effect of TST combined with Huayu Tongbian Decoction in the treatment of rectocele(Qixu Xueyu type)of middle-aged and elderly women.Materials and Methods: There were 105 middle-aged and elderly women with rectocele(Qixu Xueyu type)selected for this research,and all of them were admitted to the Anorectal Department of The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine between January 2018 and June 2019.They were divided into three groups,according to the random number table method,which were the observation group(TST + Huayu Tongbian Decoction),the control group ?(Block + Huayu Tongbian Decoction),and the control group ?(TST + Mosapride).There were 35 cases in each group.SPSS20.0 statistical software was used to analyze the scores of defecation symptoms,the observation indexes of operation effect,effective rates,obvious efficiency and recurrence rates of all patients in different groups.It would also evaluate the clinical effect of TST combined with Huayu Tongbian Decoction in the treatment of rectocele(Qixu Xueyu type)of middle-aged and elderly women.Results:1.Shedding Rate: There were 105 cases in this study and they were divided evenly into 3 groups,which meant 35 cases in one group.Among them,the observation group lost two cases;the control group ? lost three cases;and the control group ? lost one case.Therefore,99 cases were completed in this research,of which 33 cases were in the observation group,32 cases were in the control group ? and another 34 cases were in the control group ?.The total shedding rate was 5.71%(6/105).2.Safety Indicator: After 2 weeks of the operation,there were no signigicantly differences for the indexes of liver function and kidney function of patients in these three groups compared with figures before the operation(P > 0.05).3.Comparison of Defecation Symptom Score: Before the operation,there were no significant differences of the total score of defecation symtom among the observation group(39.76 ± 3.80),the control group ?(38.94 ± 4.31,t = 0.81,P = 0.42),and the observation group and the control group ?(38.59 ± 4.19,t = 1.20,P = 0.24).At 1 week after the operation,the total score of defecation symptom in the observation group(20.48 ± 5.22)was significantly different from that in the control group ?(23.56 ± 5.12).At 2 weeks after the operation,the total score of defecation symptom in the observation group(12.30 ± 5.25)was significantly lower than that in the control group ?(16.81 ± 6.46,P = 0.00)and the control group ?(15.29 ± 6.19,P = 0.04).4.Comparison of Operation Time and Hospitalization Time: The operation time of the observation group(18.82±2.92)was significantly shorter than that of the control group ?(24.76 ± 2.89,P = 0.00),while there was no obvious difference between the observation group and the control group ?(18.54 ± 3.19,P = 0.71);the hospitalization days of the observation group(9.00 ± 1.77)was significantly different from the control group ?(12.66 ± 2.22,P = 0.00)and the control group ?(10.09 ± 2.12,P = 0.03).5.Comparison of Postoperative Pomplications: The incidence of postoperative pain,postoperative bleeding,and postoperative urinary retention in the observation group were significantly lower than those in the control group ?(P < 0.05),while there were no significant differences compared with the control group ?(P > 0.05).6.Comparison of Efficacy: 2 weeks after the operation,all the symptoms of the three groups were improved with varying degrees.All the effective rates of the three treatments were 100%.However,the obvious-effective rates were slightly different,and the observation group was 60.61%,the control group ? was 53.13% and the control group ? was 55.88%.By the rank sum test,there was no significant difference between the observation group and the control group ? in clinical effect,and so it was between the observation group and the control group ?.7.The patients in the three groups did not show any significant recurrence tendency within 6 months after the operation.The symptom score of the observation group(13.27 ± 5.07)was significantly lower than the control group ?(18.50 ± 6.08)and the control group ?(16.71 ± 5.61),and was closer to the symptom score of the four weeks after the operation.Conclusions:1.TST is safe and effective in the treatment of moderate and severe RC for middle-aged and elderly women,with the advantages of shortening operation time,reducing postoperative complications,and accelerating postoperative recovery.2.Huayu Tongbian Decoction can obviously improve the clinical symptoms of RC patients with Qixu Xueyu type and could help patients Yiqi Huoxue,Huayu Tongluo,and Jiedu Tongbian.3.The combination of Huayu Tongbian Decoction and TST has a good effect on the treatment of RC(Qixu Xueyu type)in middle-aged and elderly women with a small recurrence rate,which deserves further promotion and application. |
PDF Full Text Request